For columnist Dagmar Munn, reducing uncertainty in one area of her life with ALS would mean keeping her ALS progression right where it is.
A new drug may slow progression of -- and even reverse -- symptoms of a rare form of amyotrophic lateral sclerosis, or ALS, a new study published Monday finds. The drug, tofersen, targets a very ...
Blood lactate levels were associated with survival and weight changes in ALS, according to a study in Australia and Japan.
Amyotrophic lateral sclerosis (ALS) remains one of the most devastating and biologically elusive neurodegenerative diseases. Despite decades of research, its underlying mechanisms are still not fully ...
Add Yahoo as a preferred source to see more of our stories on Google. Wheelchair, isolated view Image by Kub The Shadow Simple ManShutterstock A newly published study says that the body’s own immune ...
The growing burden of ALS in the US highlights the need for earlier diagnosis, multidisciplinary care, and expanded access to emerging therapies.
Subset analysis of patients whose ALS did not progress from a long-term survival study showed NP001 saved lung function and extended life by 22 months vs. a control group (~70% on riluzole) NP001 ...
Morning Overview on MSN
Study links an ALS-related protein to DNA repair, cancer, and dementia risk
A protein long studied for its role in amyotrophic lateral sclerosis and frontotemporal dementia now appears to serve a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results